The new Eurosurveillance website is almost here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2010: Volume 15/ Issue 29 Article 4
Back to Table of Contents
Previous Download (pdf)

Eurosurveillance, Volume 15, Issue 29, 22 July 2010
Estimation of the reproduction number for 2009 pandemic influenza A(H1N1) in the presence of imported cases
  1. PRESTO, Japan Science and Technology Agency, Saitama, Japan
  2. Theoretical Epidemiology, University of Utrecht, Utrecht, the Netherlands
  3. Institute of Information and Mathematical Sciences and New Zealand Institute for Advanced Study, Massey University, Auckland, New Zealand

Citation style for this article: Nishiura H, Roberts MG. Estimation of the reproduction number for 2009 pandemic influenza A(H1N1) in the presence of imported cases. Euro Surveill. 2010;15(29):pii=19622. Available online:
Date of submission: 09 July 2010

To the editor: Paine et al. recently reported an estimate of the reproduction number (R) for 2009 pandemic influenza A(H1N1) in New Zealand [1]. Given that early epidemiological assessments of pandemic potential (i.e. transmission potential and severity of the disease) were limited in accuracy and precision, identifying technical pitfalls in relevant past studies is of the utmost importance. While we enjoyed reading Paine et al.’s contribution [1], we believe more emphasis on the estimation framework and relevant data needs is essential for improving future studies. Namely, constructing an epidemic model involving imported cases requires particular attention to the estimation of the number of secondary cases generated by a single imported case relative to the time since immigration (i.e. arrival of the imported case into the country).

Compared with an earlier study estimating R of the pandemic influenza in New Zealand [2], a new aspect of Paine et al.’s study [1] is the method used to account for imported cases. It should be noted, however, that an earlier study in Japan, cited in [1], did not involve any imported cases and thus did not ignore this aspect [3]. Despite the improvement reported in [1], the estimate of R obtained should not be regarded as correct or as a revised estimate, as compared with [2], for the reasons given below.

To demonstrate our concerns, we have used a renewal equation (which captures the birth process of infected individuals) to describe the time dependent increase in incidence j(t) (i.e. the number of new local infections) at calendar time t. With generalisation, the modelling approach taken by Paine et al. [1] is identical to a classical branching process model with immigration [4], i.e.

where R is the reproduction number, i(t) is the number of new imported cases (incidence of imported cases) at time t and g(t) is the probability density function of the generation time of length t. Of course, the corresponding estimator of R is given by


Direct application of Equation 2 to the epidemiology of influenza results in an underestimation of R for three reasons. Here we propose a more appropriate equation than Equation 1 to describe the observed epidemiological dynamics:


where α is the relative contribution of imported cases to secondary transmission (as compared with local cases), g1(t) is the probability density function of the generation time (i.e. identical to g(t) in Equation 1), and g2(t) is a truncation of the generation time distribution, i.e. 

where t0 represents the time elapsed from infection of imported cases to their entry into New Zealand.

The first of our concerns is that the relative infectiousness, α, not only rescales g2(t) but also reflects both the intrinsic and extrinsic dynamics of imported cases (e.g. international travellers may have a smaller number of contacts than local cases and, moreover, may have been more likely to be tested than local febrile cases), which would have changed the estimate obtained in [1]. Given that the early epidemic period of interest corresponds to the containment phase, it is natural to assume that α was smaller than one. This was the case in Japan, where α = 0.15 was estimated, ignoring the difference between g1 and g2 [5]. If a were zero, employing Equation 3 would have the same effect as removing imported cases from the analysis, as in [2]. Second, failing to account for Equation 4 led to an underestimation of R in [1], although an explicit estimation of g2(t) would require substantial epidemiological and statistical effort. Third, Paine et al. [1] adopted an exponential distribution for g(t) in Equation 1, which is known to yield a smaller estimate of R compared with that from a more realistic distribution with an identical mean [6]. Although Paine et al. [1] emphasised the importance of imported cases and obtained a smaller R compared with the earlier study [2], none of the three key issues mentioned above were discussed. Without addressing these, the modelling approach of Paine et al. [1] could be interpreted as arbitrarily scaling down the magnitude of R.

Although we agree that the early estimate of R = 1.96 in New Zealand is now regarded as an overestimate, due to the observed final size of the epidemic (i.e. the proportion infected in a population by the end of first epidemic wave) and when compared with estimates of R in other countries, we believe that the underlying reasons for the overestimation have not been clarified by Paine et al. [1], leading to concerns about the modelling method. An important implication that can be drawn from this letter is that an explicit modelling approach to immigration requires us to know at least the times of infection and arrival of imported cases. In addition, understanding the frequency of contacts of travellers (in comparison with non-travellers) and empirically observing the number of secondary cases arising from imported cases would add great value when attempting to obtain a precise estimate of R. Critical assessment of early naive studies of pandemic potential must be based on a firm analytical understanding.

The work of HN was supported by the JST PRESTO program. MGR wishes to acknowledge funding from the Health Research Council under contract number 10/754.


  1. Paine S, Mercer GN, Kelly PM, Bandaranayake D, Baker MG, Huang QS, et al. Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations. Euro Surveill. 2010;15(24). pii=19591. Available from:
  2. Nishiura H, Wilson N, Baker MG. Estimating the reproduction number of the novel influenza A virus (H1N1) in a Southern Hemisphere setting: preliminary estimate in New Zealand. N Z Med. J. 2009;122(1299):73-77.
  3. Nishiura H, Castillo-Chavez C, Safan M, Chowell G. Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. Euro Surveill. 2009;14(22). pii=19227. Available from:
  4. Jagers P. Age-dependent branching processes allowing immigration. Theor Prob Appl. 1968;13(2):225-236.
  5. Nishiura H, Chowell G, Safan M, Castillo-Chavez C. Pros and cons of estimating the reproduction number from early epidemic growth rate of influenza A (H1N1) 2009. Theor Biol Med Model. 2010;7:1.
  6. Roberts MG, Heesterbeek JA. Model-consistent estimation of the basic reproduction number from the incidence of an emerging infection. J Math Biol. 2007;55(5-6):803-16.

Back to Table of Contents
Previous Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.